The Johnson & Johnson vaccine provides protection against the highly contagious Delta variant, a study found. Many U.S. states have vaccinated over 70 percent of residents, but Southern states are lagging. …
Doses of the Johnson & Johnson vaccine that were manufactured at the Emergent BioSolutions plant in Baltimore were approved for distribution by the F.D.A. on Friday.Credit…Jim Lo Scalzo/EPA, via Shutterstock
WASHINGTON — Federal regulators on Friday cleared a batch of vaccine that could furnish up to 15 million doses of Johnson & Johnson’s one-shot coronavirus vaccine, deciding they can be safely distributed despite production failures at the vaccine-making factory that ruined 75 million other doses.
The move brings the total number of Johnson & Johnson doses made at the Baltimore facility and cleared by the Food and Drug Administration for distribution in the United States to roughly 40 million. But Johnson & Johnson remains far from its goal of delivering 100 million doses to the federal government by the end of June. European Union officials have said the firm is missing its delivery targets there, as well.
The vaccine cleared on Friday is not yet bottled, and the Biden administration’s plans for it
